ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1978

Using Administrative Health Data to Construct a Frailty Index as a Measure of Susceptibility to Adverse Health Outcomes Among Individuals with Rheumatoid Arthritis

Alexandra Legge1 and Diane Lacaille2, 1Arthritis Research Canada, Dalhousie University, Halifax, NS, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

Meeting: ACR Convergence 2022

Keywords: Administrative Data, health status, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster IV

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Frailty is increasingly recognized among individuals living with RA. While several tools are available to assess frailty in clinical settings, it is less readily measured in administrative health datasets. Our aim was to develop and evaluate a frailty index (FI) for individuals with RA using administrative health data.

Methods: We conducted a population-based cohort study using administrative health data for a Canadian province from 1990 – 2018. A previously validated case definition based on physician billing data was used to assemble an incident cohort of all cases with RA onset from 1996 – 2008. To capture the health state of individuals living with RA, the baseline date was defined as 5 years after the index date for RA diagnosis. We randomly sampled 50% of the incident RA cohort for FI derivation, while the remaining 50% was used for FI validation.

Health deficits for the FI were selected using published criteria. First, 101 candidate variables were identified via literature review and evaluated in the derivation cohort for data availability, prevalence, and relationship with age. Next, 60 eligible variables were evaluated by an expert panel in a modified Delphi consensus process. Participants ranked each candidate variable’s association with adverse outcomes (0-9) and overall suitability (0-9). Forty health deficits met criteria for inclusion in the FI, which required median scores ≥ 7 with no disagreement. Each deficit was scored from 0 (absent) to 1 (present) and individual deficit scores were combined to produce a baseline FI score for each patient.

We evaluated the association of baseline FI scores with health outcomes during follow-up, including mortality, acute care hospitalizations, and emergency department (ED) visits. Follow-up began on the baseline date and continued until the earliest occurrence of death, leaving the province, or the end of the study period. Mortality risk was modelled using Cox regression, while negative binomial regression was used to model the rates of hospitalizations and ED visits during follow-up. Predictive accuracy of the FI was compared to the Romano version of the Charlson comorbidity index (CCI). Multivariable models were adjusted for age, sex, rurality, and socioeconomic status.

Results: Baseline characteristics for the derivation cohort (n=16093) and the validation cohort (n=16092) are shown in Table 1. In the derivation cohort, the distribution of baseline FI scores was right-skewed (Figure 1a), with 7% of RA patients classified as frail (FI > 0.21). FI scores increased with increasing age (Figure 1b). Baseline FI scores were associated with mortality risk and rates of hospitalizations and ED visits during follow-up (Table 2). The FI was similar to the CCI for predicting mortality, but superior for predicting hospitalizations and ED visits. Addition of the FI to existing measures improved outcome prediction. FI performance was similar in the validation cohort (Table 2).

Conclusion: The FI quantifies risk of adverse health outcomes that is not otherwise captured by demographic variables and traditional comorbidity measures in administrative health data. With further validation, the FI is a promising tool for understanding the impact of frailty on health outcomes in RA.

Supporting image 1

Figure 1

Supporting image 2

Table 1

Supporting image 3

Table 2


Disclosures: A. Legge, None; D. Lacaille, None.

To cite this abstract in AMA style:

Legge A, Lacaille D. Using Administrative Health Data to Construct a Frailty Index as a Measure of Susceptibility to Adverse Health Outcomes Among Individuals with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/using-administrative-health-data-to-construct-a-frailty-index-as-a-measure-of-susceptibility-to-adverse-health-outcomes-among-individuals-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-administrative-health-data-to-construct-a-frailty-index-as-a-measure-of-susceptibility-to-adverse-health-outcomes-among-individuals-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology